Ligand Pharma (LGND) PT Raised to $144 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $288.82 --0%
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 7
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 7
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis raised the price target on Ligand Pharma (NASDAQ: LGND) to $144.00 (from $135.00) while maintaining a Buy rating.
You May Also Be Interested In
- Bullish (BLSH) PT Lowered to $30 at Rosenblatt
- Belite Bio, Inc, ADR (BLTE) PT Raised to $220 at Mizuho
- WeRide Inc (WRD) PT Lowered to $10.70 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
